Market Closed

FDMT
4D Molecular Therapeutics
$ 12.23
0.91%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

4D Molecular Therapeutics News

Latest 4D Molecular Therapeutics Stock News & FDMT Headlines

4D Molecular Therapeutics, Inc. (FDMT) Presents at Stifel 2026 Healthcare Conference 2026 Transcript
a day ago | seekingalpha.com
4D Molecular Therapeutics, Inc. (FDMT) Reports Q3 Loss, Tops Revenue Estimates
2 days ago | zacks.com
4D Molecular Therapeutics, Inc. (FDMT) Presents at 3rd Annual Guggenheim Healthcare Innovation Conference Transcript
3 days ago | seekingalpha.com
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Stock Now Rated “Moderate Buy” by Wall Street Brokerages
8 days ago | defenseworld.net
4DMT to Participate in Upcoming Investor Conferences
12 days ago | globenewswire.com
4D Molecular Therapeutics, Inc. (FDMT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
13 days ago | zacks.com
4D Molecular Therapeutics, Inc. (FDMT) Analyst/Investor Day Transcript
24 days ago | seekingalpha.com
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Stock Has Average Price Target of $28.90
a month ago | defenseworld.net
4DMT to Host Investor Day on October 21, 2026
a month ago | globenewswire.com
4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME
2 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

FDMT
4D Molecular Therapeutics
$ 12.23
0.91%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago